Shi Yaming, Zong Yongzhong
Department of Cardiology, Yancheng Third People's Hospital, Yancheng, Jiangsu, People's Republic of China.
Braz J Cardiovasc Surg. 2020 Dec 1;35(6):891-896. doi: 10.21470/1678-9741-2019-0422.
To compare the efficacy of blind axillary vein puncture utilizing the new surface landmarks for the subclavian method.
This prospective and randomized study was performed at two cardiology medical centers in East China. Five hundred thirty-eight patients indicated to undergo left-sided pacemaker or implantable cardioverter defibrillator implantation were enrolled, 272 patients under the axillary access and 266 patients under the subclavian approach. A new superficial landmark was used for the axillary venous approach, whereas conventional landmarks were used for the subclavian venous approach. We measured lead placement time and X-ray time from vein puncture until all leads were placed in superior vena cava. Meanwhile, the rate of success of lead placement and the type and incidence of complications were compared between the two groups.
There were no significant differences between the two groups in baseline characteristics or number of leads implanted. There were high success rates for both strategies (98.6% [494/501] vs. 98.4% [479/487], P=0.752) and similar complication rates (14% [38/272] vs. 15% [40/266], P=0.702). Six cases in the control group developed subclavian venous crush syndrome and five had pneumothorax, while neither pneumothorax nor subclavian venous crush syndrome was observed in the experimental group.
We have developed a new blind approach to cannulate the axillary vein, which is as effective as the subclavian access, safer than that, and also allows to get this vein without the guidance of fluoroscopy, contrast, or echography.
比较利用新的体表标志进行盲穿腋静脉与锁骨下途径的疗效。
这项前瞻性随机研究在中国东部的两个心脏病医学中心进行。纳入538例拟行左侧起搏器或植入式心律转复除颤器植入术的患者,272例采用腋静脉途径,266例采用锁骨下途径。腋静脉途径使用一种新的体表标志,而锁骨下静脉途径使用传统标志。我们测量了从静脉穿刺到所有电极导线置入上腔静脉的导线置入时间和X线时间。同时,比较两组的导线置入成功率以及并发症的类型和发生率。
两组在基线特征或植入导线数量方面无显著差异。两种策略的成功率均较高(98.6%[494/501]对98.4%[479/487],P=0.752),并发症发生率相似(14%[38/272]对15%[40/266],P=0.702)。对照组有6例发生锁骨下静脉压迫综合征,5例发生气胸,而试验组未观察到气胸或锁骨下静脉压迫综合征。
我们开发了一种新的盲穿腋静脉插管方法,其效果与锁骨下途径相同,但更安全,且无需透视、造影或超声引导即可穿刺该静脉。